Clinical trial
Immunogenicity and Duration of Immunity in Immunosuppressed Children Vaccinated With Quadrivalent HPV Vaccine
NCT02263703 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Duration of Immunity in Immunosuppressed Children Vaccinated With Quadrivalent HPV Vaccine
- Lead sponsor
- The University of New South Wales
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- December 31, 2016
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune disease, bone marrow transplant infection, evidence of liver transplantation, inflammatory bowel disease, juvenile idiopathic arthritis, kidney transplant infection